Exela Didn't Infringe Alphagan IP: Fed. Circ.
A three-judge panel for the appeals court issued a ruling involving five patents, affirming-in-part and reversing-in-part two district court rulings, one involving Apotex's allegations that the patents were invalid and the other involving a finding that Exela infringed.
Allergan sued both Apotex and Exela in separate courts, each alleging that...
To view the full article, register now.